Evaluación y análisis de propiedades estructurales de productos de madera

Wood products focused on construction are supported by standards for the evaluation of their properties and their quality control. Due to the specific characteristics of these products, specialized laboratories with suitable equipment and qualified people are necessary to value the obtained results. This paper shows the results of the evaluations conducted during the year 2012 about different structural properties of wood products for construction: plywoods, chipboards, deckings, glued laminated timber, and cross laminated timber. The conditions that affect their quality and fitness for use are discussed, providing to the industry the necessary steps to correct failures or to optimize products and design. Last, precise indications of usefulness are given for the end users of the products.Los productos de madera destinados a la construcción están dotados de normativa de apoyo para la evaluación de sus propiedades y el control y seguimiento de su calidad. Por las particularidades del material, es necesario disponer de laboratorios especializados que aporten el equipamiento adecuado para la ejecución de dichas tareas y de personal experimentado que valore correctamente los resultados obtenidos. En este trabajo se presentan los resultados de las evaluaciones desarrolladas durante el año 2012 sobre las propiedades estructurales en distintos productos de madera destinados a la construcción (tableros contrachapados, tableros de partículas, suelos de madera para exterior, madera laminada encolada y madera contralaminada) y se debate sobre los aspectos que afectan a su calidad y adecuación al uso, aportando a la industria las medidas necesarias para la corrección de fallos o la optimización del producto y su diseño, así como proporcionar indicaciones precisas a los usuarios de los productos

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC

2016 ESC on Acute and Chronic H

Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study

Aim: This study aimed at evaluating the cost-effectiveness of different non-invasive imaging-guided strategies for the diagnosis of obstructive coronary artery disease (CAD) in a European population of patients from the Evaluation of Integrated Cardiac Imaging in Ischemic Heart Disease (EVINCI) study.Methods and results: Cost-effectiveness analysis was performed in 350 patients (209 males, mean age 59 ± 9 years) with symptoms of suspected stable CAD undergoing computed tomography coronary angiography (CTCA) and at least one cardiac imaging stress-test prior to invasive coronary angiography (ICA) and in whom imaging exams were analysed at dedicated core laboratories. Stand-alone stress-tests or combined non-invasive strategies, when the first exam was uncertain, were compared. The diagnostic end-point was obstructive CAD defined as > 50% stenosis at quantitative ICA in the left main or at least one major coronary vessel. Effectiveness was defined as the percentage of correct diagnosis (cd) and costs were calculated using country-specific reimbursements. Incremental cost-effectiveness ratios (ICERs) were obtained using per-patient data and considering “no-imaging” as reference. The overall prevalence of obstructive CAD was 28%. Strategies combining CTCA followed by stress ECHO, SPECT, PET, or stress CMR followed by CTCA, were all cost-effective. ICERs values indicated cost saving from − 969€/cd for CMR-CTCA to − 1490€/cd for CTCA-PET, − 3,09 €/cd for CTCA-SPECT and − 3776€/cd for CTCA-ECHO. Similarly when considering early revascularization as effectiveness measure.Conclusion: In patients with suspected stable CAD and low prevalence of disease, combined non-invasive strategies with CTCA and stress-imaging are cost-effective as gatekeepers to ICA and to select candidates for early revascularization.</p

Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

[No abstract available